Health ❯Healthcare ❯Vaccines

Covid-19 Vaccines

Moderna Covid Vaccine Novavax Vaccine Novavax Covid Vaccine mRNA Vaccines Moderna Market Competition Comirnaty

Moderna Reports Larger-Than-Expected Q4 Loss as COVID Vaccine Sales Plummet

Pfizer Exceeds Q4 Earnings Expectations with Strong Covid Product Sales and Cost Cuts

Moderna Cuts 2025 Revenue Forecast by $1 Billion, Shares Drop Over 20%

Moderna Stock Surges After Bird Flu Vaccine Developments and Rising Respiratory Illness Rates

FDA Authorizes New Novavax Vaccine Targeting Omicron Variant

Moderna Lowers Annual Sales Forecast Amid Competitive Vaccine Market